BPKDi
BPKDi is an inhibitor of PKD. BPKDi inhibits three members of the PKD family, PKD1, PKD2, and PKD3, with IC50 values of 1 nM, 9 nM, and 1 nM, respectively. BPKDi blocks signal-dependent phosphorylation and nuclear export of class IIa HDACs in cardiomyocytes and concomitantly suppresses hypertrophy of these cells[1].
Product Specifications
CAS Number
1201673-28-0
Product Name Alternative
d,l-SKF89976A hydrochloride
UNSPSC
12352005
Target
HDAC; PKD
Type
Reference compound
Related Pathways
Apoptosis; Cell Cycle/DNA Damage; Epigenetics
Applications
Neuroscience-Neurodegeneration
Field of Research
Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/bpkdi.html
Purity
99.60
Solubility
DMSO : 50 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
O=C(N)C1=CC(C2=CC(NC3CCCCC3)=NC=C2)=NC(N4CCNCC4)=C1
Molecular Formula
C21H28N6O
Molecular Weight
380.49
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture and light)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
PKD1; PKD2; PKD3
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
TFIIB (GTF2B) (NM_001514) Human Over-expression Lysate
Mitochondrial Marker (AE-1), CF594 conjugate, 0.1mg/mL
ENAH / MENA (Actin Regulator) (ENAH/1988), CF740 conjugate, 0.1mg/mL
CD44v6 (Marker of Tumor Metastasis) (2F10), CF647 conjugate, 0.1mg/mL
HCG-alpha (HCGa/53), CF405S conjugate, 0.1mg/mL
